Ann: Changes to Company Securities, page-26

First 26 Last

Share
Profile

Follow
mpk1980

1,544 Posts.

429

29/04/20

09:04

Post #: 44315014
Share

Originally posted by Kgre ↑

I saw what you responding to; I wrote it. ???

"Do you understand that A3D is currently printing samples for those who have shown interest under NDAs. Maybe you should take the time to visit their offices/warehouse and see it for yourself."
Doesn't sound like a question so much as a patronising bit of rhetoric.
But I'll answer it like a question anyway. How long does it take to design and print a part? 24 hours?
And, how long does it take DNV-GL to stress test a metallurgy. About same, but lets allow 7 of the same part tested to breaking point.

So now, you tell me....
Why haven't you seen the results yet? Or a client?
The only explanation I can come up with is: the parts don't meet spec. This company has demonstrated REPEATEDLY AND CONSISTENTLY that is not keeping you informed, when information is detrimental to the image shareholders have of a disruptive tech company.

$430 million value lost from its peaks. Thats 97%.
It tells you not only management, but also about the tech. There is ZERO evidence that the tech is any good, and loads that is isn't. And opportunites abound on ASX now, for bags in reputable, revenue earning companies.

The next cap raise will be an offer to retail holders, an SPP because there's nothing left here for sophs to pick over, and far better opportunites.
And the faithful will say "Wow, look the company is finally giving us long term holders a fair go".

Expand

Have a VERY good read of the announcement titled "Major Step Towards MCP Process Validation." That's independent test results!

A3D Price at posting: 9.4¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

PL3

Patagonia looks to raise $2.15M for South American exploration and development

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

There are more pages in this discussion • 2 more messages in this thread...

First 26 Last

Add A3D (ASX) to my watchlist

(20min delay)
Last 8.9¢		Change 0.000(0.00%)		Mkt cap ! $32.19M

Open	High	Low	Value	Volume
9.1¢	9.1¢	8.6¢	$139.8K	1.571M

Buyers (Bids)

No.	Vol.	Price($)
2	140586	8.6¢

Sellers (Offers)

Price($)	Vol.	No.
8.9¢	6763	1

View Market Depth

No.	Vol.	Price($)
2	140586	0.086
2	390000	0.085
1	130000	0.084
1	100000	0.083
1	1000000	0.082

Price($)	Vol.	No.
0.089	6763	1
0.090	830000	2
0.092	108706	1
0.093	50000	1
0.094	2721	1

Last trade - 16.10pm 09/07/2024 (20 minute delay)

A3D (ASX) Chart

Ann: Changes to Company Securities, page-26

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Patagonia looks to raise $2.15M for South American exploration and development

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Changes to Company Securities, page-26

Top Stories

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Patagonia looks to raise $2.15M for South American exploration and development

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News